
Minghui and Qilu Pharmaceutical to advance MHB088C in Greater China
Minghui Pharmaceutical has announced an exclusive licensing and partnership agreement with Qilu Pharmaceutical for developing, manufacturing, and commercialising MHB088C in Greater China. Under the deal, Qilu will have exclusive rights to the therapy in …